NZYM B Novozymes A/S Class B

Trading by management and close relations of management

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.

June 21, 2024

Company announcement No. 23



1.Details of the person discharging managerial responsibilities/person closely associated
a)NameNovo Holdings A/S
2.Reason for the notification
a)Position/statusNovo Holding A/S is closely related to its CEO Kasim Kutay, who is a member of Novonesis' board of directors
b)Initial notification/

Amendment
Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameNovozymes A/S, part of Novonesis Group
b)LEI529900T6WNZXD2R3JW38
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument

Identification code
B-Shares







DK0060336014
b)Nature of the transactionPurchase of shares
c)Price(s) and volume(s)Price: 441.5135

Volume: 7,623,830 shares
d)Aggregated information
  • Aggregated volume
  • Price
Number of shares: 7,623,830

Average price, DKK: 441.5135

Transaction value, DKK: 3,366,023,866
e)Date of transactionJune 20, 2024
f)Place of the transactionOutside a trading window

Contact information  
Tobias Bjorklund



 




Anders Enevoldsen



 




Disa Tuominen



 

Attachment



EN
21/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Please read the full announcement in PDF Attachments

 PRESS RELEASE

Novonesis delivered 8% organic sales growth in the first nine months o...

Novonesis delivered 8% organic sales growth in the first nine months of 2025 Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards.  COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine months of 2025. Full-year outlook is narrowed upwards to 7-8%, previously 6-8%. Ester Baiget, President & CEO:  "I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability. Our performance was strong across all sales areas and i...

 PRESS RELEASE

8% organic sales growth after first nine months. Full-year organic sal...

8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards. Ester Baiget, President & CEO: ”I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was strong across all sales areas and in Emerging and Developed Markets. We delivered 37.3% adjusted EBITDA margin, despite significant currency headwinds, demonstrating the strength and resilience of our business model. Following a robust nine-months performance including favorable timing in the third quar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch